| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2022 | PGXL TECHNOLOGIES LLC | 1817 BROWNSBORO RD | LOUISVILLE | KY | 40206-2111 | JEFFERSON | USA | R43DD001299 | A sleep biomarker test for management of ADHD | 01 | 1 | CDC | 10/10/2023 | $0 |
| 2024 | 2022 | PGXL TECHNOLOGIES LLC | 1817 BROWNSBORO RD | LOUISVILLE | KY | 40206-2111 | JEFFERSON | USA | R43DD001299 | A sleep biomarker test for management of ADHD | 02 | 1 | CDC | 2/2/2024 | $0 |
| 2024 | 2022 | PGXL TECHNOLOGIES LLC | 1817 BROWNSBORO RD | LOUISVILLE | KY | 40206-2111 | JEFFERSON | USA | R43DD001299 | A sleep biomarker test for management of ADHD | 01 | 1 | CDC | 10/10/2023 | $0 |
| 2024 | 2022 | PGXL TECHNOLOGIES LLC | 1817 BROWNSBORO RD | LOUISVILLE | KY | 40206-2111 | JEFFERSON | USA | R43DD001299 | A sleep biomarker test for management of ADHD | 02 | 1 | CDC | 2/2/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $309,250 ) |
| 2022 | 2022 | PGXL TECHNOLOGIES, LLC | 1817 BROWNSBORO RD | LOUISVILLE | KY | 40206-2111 | JEFFERSON | USA | R43DD001299 | A sleep biomarker test for management of ADHD | 00 | 1 | CDC | 8/12/2022 | $10,081 |
| 2022 | 2022 | PGXL TECHNOLOGIES, LLC | 1817 BROWNSBORO RD | LOUISVILLE | KY | 40206-2111 | JEFFERSON | USA | R43DD001299 | A sleep biomarker test for management of ADHD | 00 | 1 | CDC | 8/12/2022 | $299,169 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| 2020 | 2017 | PGXL TECHNOLOGIES, LLC | 1817 BROWNSBORO RD | LOUISVILLE | KY | 40206-2111 | JEFFERSON | USA | R43HL136220 | A Non-invasive Assay for Obstructive Sleep Apnea | 000 | 1 | NIH | 2/15/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| 2019 | 2017 | PGXL TECHNOLOGIES, LLC | 12123 SHELBYVILLE ROAD SUITE 100 | LOUISVILLE | KY | 40243-1079 | JEFFERSON | USA | R43HL136220 | A Non-invasive Assay for Obstructive Sleep Apnea | 000 | 1 | NIH | 12/28/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $224,628 ) |
| 2017 | 2017 | PGXL TECHNOLOGIES, LLC | 201 E JEFFERSON ST | LOUISVILLE | KY | 40202-1246 | JEFFERSON | USA | R43HL136220 | A Non-invasive Assay for Obstructive Sleep Apnea | 000 | 1 | NIH | 7/9/2017 | $224,628 |
|
|